Cynthia Owusu1, Seunghee Margevicius2, Mark Schluchter2, Siran M Koroukian2, Nathan A Berger3. 1. Division of Hematology/Oncology, Department of Medicine, Case Western Reserve School of Medicine, United States; Case Comprehensive Cancer Center, Cleveland, OH, United States. Electronic address: Cynthia.owusu@case.edu. 2. Case Comprehensive Cancer Center, Cleveland, OH, United States; Department of Epidemiology and Biostatistics, Case Western Reserve School of Medicine, United States. 3. Division of Hematology/Oncology, Department of Medicine, Case Western Reserve School of Medicine, United States; Case Comprehensive Cancer Center, Cleveland, OH, United States.
Abstract
OBJECTIVE: To determine the ability of three performance-based measures [Short Physical Performance Battery (SPPB), gait speed, and Grip Strength] and a self-report measure [Vulnerable Elders Survey (VES-13)] to predict functional decline among older women with breast cancer. PATIENTS AND METHODS: Longitudinal data from a study of women ≥65years, with newly diagnosed stages I-III breast cancer, recruited from ambulatory oncology clinics between July 2010 and April 2014, was used. The primary outcome was functional decline, Yes or No, defined as a decrease in ≥1-point from baseline to 12months, on Activities of Daily Living Scales. Multivariable logistic regression and receiver operator curve analyses were conducted. RESULTS: Among 123 participants 18 (15%) developed functional decline. The predictive abilities for measures were: SPPB [Adjusted odds ratio (AOR)=1.65 per unit decrease in scores, 95% confidence interval (CI)=1.33-2.05; area under the receiver operator curve (AUC)=0.93; sensitivity=94%, specificity=80%]; gait speed (AOR=1.76 per unit increase in usual walking time, CI=1.29-2.41; AUC=0.93; sensitivity=87%, specificity=79%); VES-13 (AOR=1.64 per unit increase in scores, CI=1.31-2.05; AUC=0.87; sensitivity=83%, specificity=84%); and grip strength: (AOR=1.18 per unit decrease in grip strength, CI=1.06-1.30; AUC=0.80; sensitivity=67%, specificity=77%). CONCLUSION: SPPB, gait speed, grip strength and VES-13 all demonstrated excellent predictive abilities for functional decline. Larger studies are warranted to confirm the utility of these measures for identifying older adults with cancer at increased risk for functional decline, who may then be targeted for studies to explore the effects of interventions to improve function.
OBJECTIVE: To determine the ability of three performance-based measures [Short Physical Performance Battery (SPPB), gait speed, and Grip Strength] and a self-report measure [Vulnerable Elders Survey (VES-13)] to predict functional decline among older women with breast cancer. PATIENTS AND METHODS: Longitudinal data from a study of women ≥65years, with newly diagnosed stages I-III breast cancer, recruited from ambulatory oncology clinics between July 2010 and April 2014, was used. The primary outcome was functional decline, Yes or No, defined as a decrease in ≥1-point from baseline to 12months, on Activities of Daily Living Scales. Multivariable logistic regression and receiver operator curve analyses were conducted. RESULTS: Among 123 participants 18 (15%) developed functional decline. The predictive abilities for measures were: SPPB [Adjusted odds ratio (AOR)=1.65 per unit decrease in scores, 95% confidence interval (CI)=1.33-2.05; area under the receiver operator curve (AUC)=0.93; sensitivity=94%, specificity=80%]; gait speed (AOR=1.76 per unit increase in usual walking time, CI=1.29-2.41; AUC=0.93; sensitivity=87%, specificity=79%); VES-13 (AOR=1.64 per unit increase in scores, CI=1.31-2.05; AUC=0.87; sensitivity=83%, specificity=84%); and grip strength: (AOR=1.18 per unit decrease in grip strength, CI=1.06-1.30; AUC=0.80; sensitivity=67%, specificity=77%). CONCLUSION: SPPB, gait speed, grip strength and VES-13 all demonstrated excellent predictive abilities for functional decline. Larger studies are warranted to confirm the utility of these measures for identifying older adults with cancer at increased risk for functional decline, who may then be targeted for studies to explore the effects of interventions to improve function.
Authors: Cynthia Owusu; Mark Schluchter; Siran M Koroukian; Suzanne Mazhuvanchery; Nathan A Berger Journal: Cancer Date: 2013-09-23 Impact factor: 6.860
Authors: Jacqueline J Suijker; Bianca M Buurman; Marjon van Rijn; Marlies T van Dalen; Gerben ter Riet; Nan van Geloven; Rob J de Haan; Eric P Moll van Charante; Sophia E de Rooij Journal: J Clin Epidemiol Date: 2014-08-04 Impact factor: 6.437
Authors: T Rantanen; J M Guralnik; R Sakari-Rantala; S Leveille; E M Simonsick; S Ling; L P Fried Journal: Arch Phys Med Rehabil Date: 1999-02 Impact factor: 3.966
Authors: G Abellan van Kan; Y Rolland; S Andrieu; J Bauer; O Beauchet; M Bonnefoy; M Cesari; L M Donini; S Gillette Guyonnet; M Inzitari; F Nourhashemi; G Onder; P Ritz; A Salva; M Visser; B Vellas Journal: J Nutr Health Aging Date: 2009-12 Impact factor: 4.075
Authors: Lillian Min; William Yoon; Jeff Mariano; Neil S Wenger; Marc N Elliott; Caren Kamberg; Debra Saliba Journal: J Am Geriatr Soc Date: 2009-09-28 Impact factor: 5.562
Authors: Kah Poh Loh; Supriya G Mohile; Ronald M Epstein; Colin McHugh; Marie Flannery; Eva Culakova; Lianlian Lei; Megan Wells; Nikesha Gilmore; Dilip Babu; Mary I Whitehead; William Dale; Arti Hurria; Marsha Wittink; Allison Magnuson; Alison Conlin; Melanie Thomas; Jeffrey Berenberg; Paul R Duberstein Journal: Cancer Date: 2019-03-28 Impact factor: 6.860
Authors: Andrea Sitlinger; Rebecca A Shelby; Alyssa N Van Denburg; Heidi White; Sarah N Edmond; Paul K Marcom; Hayden B Bosworth; Francis J Keefe; Gretchen G Kimmick Journal: J Geriatr Oncol Date: 2018-12-13 Impact factor: 3.599
Authors: Supriya G Mohile; William Dale; Mark R Somerfield; Mara A Schonberg; Cynthia M Boyd; Peggy S Burhenn; Beverly Canin; Harvey Jay Cohen; Holly M Holmes; Judith O Hopkins; Michelle C Janelsins; Alok A Khorana; Heidi D Klepin; Stuart M Lichtman; Karen M Mustian; William P Tew; Arti Hurria Journal: J Clin Oncol Date: 2018-05-21 Impact factor: 44.544
Authors: Cynthia Owusu; Seunghee Margevicius; Nora L Nock; Kristina Austin; Elizabeth Bennet; Stephen Cerne; Paul Hergenroeder; Halle C F Moore; Jean Petkac; Mark Schluchter; Kathryn H Schmitz; Monica Webb Hooper; Leonard Wimbley; Nathan A Berger Journal: Cancer Date: 2022-03-15 Impact factor: 6.921
Authors: Cynthia Owusu; Nora L Nock; Paul Hergenroeder; Kristina Austin; Elizabeth Bennet; Stephen Cerne; Halle Moore; Jean Petkac; Mark Schluchter; Kathryn H Schmitz; Monica Webb Hooper; Lindsay Atkins; Oghenerukeme Asagba; Leonard Wimbley; Nathan A Berger Journal: Contemp Clin Trials Date: 2020-04-15 Impact factor: 2.226